Valeo Pharma Announces Short Form Prospectus Unit Offering and Refiling of Its Condensed Consolidated Interim Financial Statements and Related MD&A

    NEXT STORY
    Innovation Pharmaceuticals Receives FDA End-of-Phase 2 Meeting Minutes
    PREV STORY
    Allogene Therapeutics Announces Expansion of Scientific Advisory Board
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Immunicum AB (publ) Announces Upcoming Investor Events in October and November

    Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October ...

    author_avatar
    NASDAQ Market News

    Nuritas Announces Formation of Scientific Advisory Board

    DUBLIN, Ireland, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Nuritas, a biotechnology company discovering life-changing ...

    author_avatar
    NASDAQ Market News

    NanoVibronix Announces Publication of Study Measuring the Effect of Surface Acoustic Waves on Bacterial Load and Preventing Catheter-Associated Urinary Tract Infections

    UroShield™ reduced Colony Forming Units (CFU) count from >100,000 to 10,000 CFU or less ...

    author_avatar
    NASDAQ Market News